HeartBeam, Inc. financial data

Symbol
BEAT, BEATW on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
2118 Walsh Ave., Suite 210, Santa Clara, CA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Debt-to-equity 8.48 % -56.3%
Return On Equity -121 % +41.2%
Return On Assets -112 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 26.6M shares +0.95%
Common Stock, Shares, Outstanding 26.6M shares +2.2%
Entity Public Float 21.4M USD +232%
Common Stock, Value, Issued 3K USD 0%
Weighted Average Number of Shares Outstanding, Basic 26.6M shares +34.9%
Weighted Average Number of Shares Outstanding, Diluted 26.6M shares +34.9%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 8.91M USD +39.9%
General and Administrative Expense 8.82M USD +4.32%
Operating Income (Loss) -17.7M USD -19.6%
Nonoperating Income (Expense) 809K USD +244%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -16.9M USD -16%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -16.9M USD -16%
Earnings Per Share, Basic -0.42 USD/shares +72.9%
Earnings Per Share, Diluted -0.42 USD/shares +72.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 9.16M USD -47.4%
Cash, Cash Equivalents, and Short-term Investments 19.2M USD
Assets, Current 9.7M USD -55.2%
Property, Plant and Equipment, Net 370K USD
Other Assets, Noncurrent 55K USD
Assets 10.1M USD
Liabilities, Current 1.42M USD
Liabilities 1.42M USD +149%
Retained Earnings (Accumulated Deficit) -46.4M USD -57.4%
Stockholders' Equity Attributable to Parent 8.71M USD -58.7%
Liabilities and Equity 10.1M USD -53.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -3.46M USD -11.2%
Net Cash Provided by (Used in) Financing Activities 0 USD -100%
Net Cash Provided by (Used in) Investing Activities -88K USD
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 26.6M shares +2.2%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -3.55M USD -36.4%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 9.21M USD -47.1%
Deferred Tax Assets, Valuation Allowance 9.09M USD +50.3%
Deferred Tax Assets, Gross 9.09M USD +50.3%
Payments to Acquire Property, Plant, and Equipment 88K USD
Deferred Tax Assets, Operating Loss Carryforwards 5.8M USD +40.9%
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 287K USD +61%
Additional Paid in Capital 55.1M USD +9.01%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 4.36M USD +143%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%